Research News and Research

RSS

Workers exposed to welding fumes may face risk of developing brain damage

New research suggests that workers exposed to welding fumes may be at risk for developing brain damage in an area of the brain also affected in Parkinson's disease. The study is published in the April 6, 2011, online issue of Neurology, the medical journal of the American Academy of Neurology.

7 Apr 2011

Senate approves measure to repeal health law's 1099 reporting provision

The Senate on Tuesday voted overwhelmingly to repeal the health care law's 1099 tax-reporting provision, ending nearly a year's worth of efforts to do away with one of its most unpopular requirements. The repeal measure, which passed the House last month, now goes to President Obama for his signature.

7 Apr 2011

Busy roads around pregnant woman's home increases likelihood of premature birth of baby

Babies are born earlier when their mothers live near a concentration of freeways and main roads, a study of 970 mothers and their newborn babies in Logan City, south of Brisbane, has found.

7 Apr 2011

Progesterone gel can reduce preterm birth in women with short cervix

A groundbreaking clinical study of a new method for preventing premature birth in millions of women each year, published in the medical journal Ultrasound in Obstetrics & Gynecology, shows that the rate of early preterm delivery in women can be reduced by 45 percent - simply by treating pregnant women at risk with a low-cost gel of natural progesterone during the midtrimester of pregnancy until term.

7 Apr 2011

Progesterone benefits women with short cervix, finds NIH study

A National Institutes of Health study has found that progesterone, a naturally occurring hormone, reduced the rate of preterm birth before the 33rd week of pregnancy by 45 percent among one category of at risk women.

7 Apr 2011

VBL's VB-111 preclinical data against metastatic cancer presented at AACR meeting

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced preclinical data demonstrating VB-111's potential utility as a targeted cancer treatment.

7 Apr 2011

Parkinson's disease linked to increased risk of prostate cancer

University of Utah School of Medicine researchers have found compelling evidence that Parkinson's disease is associated with an increased risk of prostate cancer and melanoma, and that this increased cancer risk also extends to close and distant relatives of individuals with Parkinson's disease.

7 Apr 2011

New PSA test identifies men with prostate cancer more accurately

In a large multi-center clinical trial, a new PSA test to screen for prostate cancer more accurately identified men with prostate cancer -- particularly the aggressive form of the disease -- and substantially reduced false positives compared to the two currently available commercial PSA tests, according to newly published research from Northwestern Medicine.

7 Apr 2011

Study: New cancer drug shrinks tumors in mouse model with few side effects

A study led by researchers at the University of Michigan Comprehensive Cancer Center showed in animal studies that new cancer drug compounds they developed shrank tumors, with few side effects.

7 Apr 2011

Opinions: Doctor shortages; harm reduction

In his column in the Guardian, Jonathan Wolff, a professor of philosophy at University College London, says despite the U.S. being viewed as having the best system of higher education in the world, the country "simply does not train enough doctors to meet its voracious appetite for medical attention" and therefore "is compelled to raid the world to make up the difference."

7 Apr 2011

AstraZeneca receives FDA approval for vandetanib to treat medullary thyroid cancer

The U.S. Food and Drug Administration today approved vandetanib to treat adult patients with late-stage (metastatic) medullary thyroid cancer who are ineligible for surgery and who have disease that is growing or causing symptoms.

7 Apr 2011

Strawberries for prevention of esophageal cancer: Study

According to a preliminary study released Wednesday, strawberries have the potential to prevent esophageal cancer. Researchers, led by Ohio State University have shown that freeze-dried strawberries slowed the growth of dysplastic, or precancerous, lesions in about 30 people who consumed the fruit for six months. Study's lead researcher, Tong Chen, an assistant professor in the oncology division of Ohio State University, presented the study at the American Association for Cancer Research's annual meeting.

6 Apr 2011

Estrogen therapy for menopause, study looks at risks-benefits

...

6 Apr 2011

Childhood obesity: Positive & negative trends

According to the latest study, fewer Australian pre-schoolers are overweight in recent years compared with the late-1990s and also the social disparities in children's obesity risk seem to be shrinking. These findings were reported in the International Journal of Obesity.

6 Apr 2011

Cigarette packaging in olive green to deter smokers

In a bid to reduce smoking rates in Australia, all cigarette packs will be packaged olive green. Under the new laws to be proposed in federal parliament, all logos will be removed from cigarette packs and brand names displayed in a specific font.

6 Apr 2011

Ascletis raises $100 million in committed financing

Ascletis, Inc., a U.S.-China specialty life sciences venture focused on cancer and infectious disease therapeutics, today announced the company's formation and completion of a Series A private equity financing. Ascletis has raised US$100 million in committed financing including a first tranche of US$50 million. The investors, led by Hangzhou Binjiang Investment Holding Co., Ltd., included private entrepreneurs from China and other countries including the United States.

6 Apr 2011

Strawberries may slow progression of precancerous lesions in the esophagus

Freeze-dried strawberries may be an alternative to drugs for the prevention of esophageal cancer, according to research presented at the AACR 102nd Annual Meeting 2011, held here April 2-6.

6 Apr 2011

First Editon: April 6, 2011

Today's headlines include stories and analysis of how the Ryan budget plan would change Medicare, Medicaid and the shape of the federal government.

6 Apr 2011

ImClone Systems initiates IMC-3C5 Phase 1 trial in patients with advanced solid tumours

Circadian Technologies announced today that its licensee ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, has advised that it has commenced the first Phase 1 clinical trial of its fully-human monoclonal antibody IMC-3C5.

6 Apr 2011

Viking expects record sales of $3.0 million for quarter ended March 31, 2011

Viking Systems, Inc., a leading worldwide developer, manufacturer and marketer of 3D and 2D visualization solutions for complex minimally invasive surgery, expects to report record sales for the quarter ended March 31, 2011 that will exceed $3.0 million, an increase of more than 50% compared with $1.9 million in revenue reported for last year's first quarter, and more than a 30% sequential increase over the fourth quarter of 2010.

6 Apr 2011